120 related articles for article (PubMed ID: 26086116)
41. Reaction to topical capsaicin in spinal cord injury patients with and without central pain.
Finnerup NB; Pedersen LH; Terkelsen AJ; Johannesen IL; Jensen TS
Exp Neurol; 2007 May; 205(1):190-200. PubMed ID: 17346705
[TBL] [Abstract][Full Text] [Related]
42. Topically applied capsaicin inhibits sensitivity to touch but not to warmth or heat-pain in the region of secondary mechanical hyperalgesia.
Drummond PD; Blockey P
Somatosens Mot Res; 2009 Dec; 26(4):75-81. PubMed ID: 20047508
[TBL] [Abstract][Full Text] [Related]
43. [New concepts in the pathophysiology, diagnosis and treatment of neuropathic pain].
Suter MR; Sprenger T; Taub E; Besson M
Rev Med Suisse; 2013 Jun; 9(392):1346, 1348-50. PubMed ID: 23882911
[TBL] [Abstract][Full Text] [Related]
44. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
Trbovich M; Yang H
Am J Phys Med Rehabil; 2015 Aug; 94(8):e66-72. PubMed ID: 26035723
[TBL] [Abstract][Full Text] [Related]
45. Topical capsaicin response as a phenotypic measure in patients with pain.
Haroutounian S; Nikolajsen L; Finnerup NB; Jensen TS
Pain Med; 2015 Apr; 16(4):823-5. PubMed ID: 25521547
[No Abstract] [Full Text] [Related]
46. [Peculiarities of age changes of NF200(+)-neurons in the sensory ganglia of different segmental levels after chemical deafferentation].
Porseva VV; Shilkin VV; Korzina MB; Smirnova VP; Masliukov PM
Morfologiia; 2012; 142(4):37-42. PubMed ID: 23236889
[TBL] [Abstract][Full Text] [Related]
47. [Capsaicin in treatment of neuropathic pain].
Kamchatnov PR; Evzelman MA; Abusueva BA; Volkov AI
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):139-44. PubMed ID: 25629137
[TBL] [Abstract][Full Text] [Related]
48. Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy.
Musharraf MU; Ahmad Z; Yaqub Z
J Ayub Med Coll Abbottabad; 2017; 29(3):384-387. PubMed ID: 29076666
[TBL] [Abstract][Full Text] [Related]
49. Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
You DS; Haney R; Albu S; Meagher MW
Headache; 2018 Jan; 58(1):62-77. PubMed ID: 29094347
[TBL] [Abstract][Full Text] [Related]
50. Antinociceptive effects of citronellal in formalin-, capsaicin-, and glutamate-induced orofacial nociception in rodents and its action on nerve excitability.
Quintans-Júnior LJ; Melo MS; De Sousa DP; Araujo AA; Onofre AC; Gelain DP; Gonçalves JC; Araújo DA; Almeida JR; Bonjardim LR
J Orofac Pain; 2010; 24(3):305-12. PubMed ID: 20664833
[TBL] [Abstract][Full Text] [Related]
51. TRPA1 contributes to capsaicin-induced facial cold hyperalgesia in rats.
Honda K; Shinoda M; Furukawa A; Kita K; Noma N; Iwata K
Eur J Oral Sci; 2014 Dec; 122(6):391-6. PubMed ID: 25371244
[TBL] [Abstract][Full Text] [Related]
52. The capsaicin 8% patch for peripheral neuropathic pain.
England J; Wagner T; Kern KU; Roth-Daniek A; Sell A
Br J Nurs; 2011 Aug 11-Sep 8; 20(15):926-31. PubMed ID: 21841657
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278
[TBL] [Abstract][Full Text] [Related]
54. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
Treede RD; Wagner T; Kern KU; Husstedt IW; Arendt G; Birklein F; Cegla T; Freynhagen R; Gockel HH; Heskamp ML; Jager H; Joppich R; Maier C; Leffler A; Nagelein HH; Rolke R; Seddigh S; Sommer C; Stander S; Wasner G; Baron R
Curr Med Res Opin; 2013 May; 29(5):527-38. PubMed ID: 23444968
[TBL] [Abstract][Full Text] [Related]
55. Pregabalin reduces acute inflammatory and persistent pain associated with nerve injury and cancer in rat models of orofacial pain.
Hummig W; Kopruszinski CM; Chichorro JG
J Oral Facial Pain Headache; 2014; 28(4):350-9. PubMed ID: 25347171
[TBL] [Abstract][Full Text] [Related]
56. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
Ellison N; Loprinzi CL; Kugler J; Hatfield AK; Miser A; Sloan JA; Wender DB; Rowland KM; Molina R; Cascino TL; Vukov AM; Dhaliwal HS; Ghosh C
J Clin Oncol; 1997 Aug; 15(8):2974-80. PubMed ID: 9256142
[TBL] [Abstract][Full Text] [Related]
57. Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
Kim SM; Kim J; Kim E; Hwang SJ; Shin HK; Lee SE
Neurosci Lett; 2008 Mar; 433(3):199-204. PubMed ID: 18242851
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
59. Agreement between quantitative and qualitative sensory testing of changes in oro-facial somatosensory sensitivity.
Agbaje J; De Laat A; Constantinus P; Svensson P; Baad-Hansen L
J Oral Rehabil; 2017 Jan; 44(1):30-42. PubMed ID: 27770480
[TBL] [Abstract][Full Text] [Related]
60. [Oxidative modification of rat blood proteins after destruction capsaicin-sensitive nerve and change of nitric oxide level].
Tolochko ZS; Spiridonov VK
Ross Fiziol Zh Im I M Sechenova; 2010 Jan; 96(1):77-84. PubMed ID: 20297694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
